| Literature DB >> 31431867 |
Kazuyoshi Kobayashi1, Kei Ando1, Fumihiko Kato2, Tokumi Kanemura3, Koji Sato4, Yudo Hachiya5, Yuji Matsubara6, Mitsuhiro Kamiya7, Yoshihito Sakai8, Hideki Yagi9, Ryuichi Shinjo10, Naoki Ishiguro1, Shiro Imagama1.
Abstract
STUDYEntities:
Keywords: length of stay; multicenter; posterior lumbar interbody fusion (PLIF); postoperative complications; transforaminal lumbar interbody fusion (TLIF)
Year: 2018 PMID: 31431867 PMCID: PMC6686383 DOI: 10.1177/2192568218800054
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.Age distribution (n = 1168).
Patient Demographics (n = 1168).
| Characteristic | n (%) |
|---|---|
| Age (years) | |
| 18-39 | 46 (3.9) |
| 40-49 | 71 (6.1) |
| 50-59 | 128 (10.9) |
| 60-69 | 339 (29.0) |
| 70-79 | 501 (42.9) |
| ≥80 | 83 (7.1) |
| Sex | |
| Female | 566 (48.5) |
| Body mass index (kg/m2) | |
| <18 | 20 (1.7) |
| 18-22 | 232 (19.9) |
| 22-25 | 510 (43.7) |
| 25-30 | 337 (28.9) |
| >30 | 69 (5.9) |
| Ambulation | |
| Independent | 873 (74.7) |
| Need assistance | 272 (23.3) |
| Wheelchair | 23 (2.0) |
| American Society of Anesthesiologists grade | |
| I | 521 (44.6) |
| II | 587 (50.2) |
| III | 55 (4.7) |
| IV | 5 (0.4) |
| Comorbidities | |
| Hypertension | 449 (38.3) |
| Smoker | 227 (19.4) |
| Diabetes mellitus | 165 (14.1) |
| Heart disease | 130 (11.1) |
| Pulmonary disease | 54 (4.6) |
| Renal comorbidities | 26 (2.2) |
| Depression | 26 (2.2) |
| Anxiety | 31 (2.6) |
| Nonspinal malignancy | 52 (4.4) |
| Main indications | |
| Spondylolisthesis | 471 (40.3) |
| Lumbar spinal stenosis, | 449 (38.4) |
| Disc herniation | 162 (13.9) |
| Adjacent segment degeneration | 39 (3.3) |
| Others | 47 (4.0) |
| Previous spinal surgery | 58 (5.0) |
Surgical Variables (n = 1168).
| Variable | n (%) |
|---|---|
| Procedures | |
| Open PLIF | 671 (57.4) |
| Open TLIF | 443 (37.9) |
| MIS-PLIF | 22 (1.9) |
| MIS-TLIF | 32 (2.7) |
| Number of levels fused | |
| 1 | 866 (74.1) |
| 2 | 209 (17.9) |
| 3 | 72 (6.2) |
| 4 | 21 (1.8) |
| Instrumented level | |
| Above L5-S1 | 654 (56.0) |
| Including L5-S1 | 514 (44.0) |
| Complications | |
| Dural tear | 50 (4.3) |
| Surgical site infection | 27 (2.3) |
| Urinary tract infection | 16 (1.4) |
| Pneumonia | 11 (0.9) |
| Deep vein thrombosis | 10 (0.8) |
| Epidural hematoma | 9 (0.9) |
| Screw misplacement | 3 (0.3) |
| Estimated blood loss (mL), mean ± SD | 481.1 ± 641.6 |
| Operative time (min), mean ± SD | 192.0 ± 90.7 |
| Reoperation | 20 (1.7) |
| Use of colloids | 97 (8.3) |
| Length of stay (days), mean ± SD | 20.6 ± 9.8 |
Figure 2.Length of stay (LOS) after posterior/transforaminal lumbar interbody fusion (PLIF/TLIF). Cases with prolonged LOS (≥75th percentile) are shown to the right of the vertical dashed line.
Figure 3.A significant positive correlation was observed between length of stay (LOS) and age (P < .05).
Characteristics of Patient With Normal and Prolonged LOS After Lumbar Posterior Fixation.
| Variable | Normal LOS | Prolonged LOS |
|
|---|---|---|---|
| Total (n) | 886 | 282 | |
| Preoperative variables, % | |||
| Age ≥70 years | 46.6 | 59.9 | <.01 |
| Female | 47.6 | 50.7 | NS |
| BMI >25 kg/m2 | 34.3 | 35.8 | NS |
| BMI >30 kg/m2 | 5.6 | 6.7 | NS |
| Ambulation: Independent | 75.2 | 73.4 | NS |
| ASA class ≥III | 4.6 | 8.1 | <.05 |
| Previous surgery | 4.9 | 5.0 | NS |
| Comorbidities variables, % | |||
| Smoker | 19.6 | 18.4 | NS |
| Diabetes mellitus | 11.2 | 23.0 | <.01 |
| Hypertension | 35.2 | 47.8 | <.01 |
| Cardiac comorbidities | 9.7 | 15.6 | <.01 |
| Pulmonary comorbidities | 4.3 | 5.3 | NS |
| Renal comorbidities | 2.2 | 2.1 | NS |
| Depression | 2.1 | 2.4 | NS |
| Anxiety | 2.4 | 3.5 | NS |
| Nonspinal malignancy | 3.7 | 6.4 | NS |
| Surgical variables, % | |||
| Open PLIF/TLIF | 94.3 | 98.9 | <.01 |
| Fused levels ≥2 | 24.7 | 41.1 | <.01 |
| Fused levels ≥3 | 4.3 | 19.1 | <.01 |
| Operative time ≥240 min | 4.7 | 19.9 | <.01 |
| Operative time ≥300 min | 13.2 | 29.7 | <.01 |
| EBL ≥500 mL | 17.4 | 29.7 | <.01 |
| Instrumented level (above L5-S1) | 56.8 | 53.5 | NS |
| Complications variables, % | |||
| Urinary tract infection | 1.1 | 2.2 | NS |
| Dural tear | 3.6 | 6.3 | <.05 |
| Surgical site infection | 0.7 | 7.4 | <.01 |
| Deep vein thrombosis | 0.2 | 2.8 | <.01 |
| Epidural hematoma | 0.3 | 2.1 | <.01 |
| Pneumonia | 0.2 | 3.2 | <.01 |
| Screw misplacement | 0.2 | 0.4 | NS |
| LOS (days), mean ± SD | 16.5 ± 4.3 | 38.2 ± 20.9 | <.01 |
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; EBL, estimated blood loss; LOS, length of stay; NS, nonsignificant; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.
Univariate and Multivariate Logistic Regression Analysis for Prolonged Length of Stay.
| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| |
| Preoperative variables | ||||
| Age ≥70 years | 2.58 (1.37-5.82) | <.01 | 1.87 (1.38-2.54) | <.01 |
| ASA class ≥III | 2.41 (1.42-5.24) | <.05 | 1.52 (1.04-2.25) | <.05 |
| Diabetes mellitus | 1.42 (1.24-2.78) | <.01 | ||
| Hypertension | 1.84 (1.04-3.26) | <.01 | ||
| Cardiac comorbidities | 1.32 (1.09-2.45) | <.01 | ||
| Perioperative variables | ||||
| Open PLIF/TLIF, % | 8.82 (2.17-23.12) | <.01 | 5.84 (1.74-19.63) | <.01 |
| Fused levels ≥2, % | 2.13 (1.37-3.97) | <.01 | ||
| Fused levels ≥3, % | 6.88 (2.41-12.43) | <.01 | 5.17 (3.17-8.43) | <.01 |
| Operative time ≥240 min, % | 1.75 (1.15-3.75) | <.01 | ||
| Operative time ≥300 min, % | 2.74 (1.35-4.64) | <.01 | 1.88 (1.15-3.07) | <.05 |
| Estimated blood loss ≥500 mL, % | 2.36 (1.32-3.95) | <.01 | 1.71 (1.07-2.75) | <.05 |
| Dural tear | 1.89 (1.06-4.21) | <.05 | ||
Abbreviations: ASA, American Society of Anesthesiologists; CI, confidence interval; OR, odds ratio adjusted for age; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.